Taipei Exchange - Delayed Quote TWD

Medigen Biotechnology Corp. (3176.TWO)

30.80
-0.20
(-0.65%)
At close: 1:30:40 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,620,757
1,372,701
1,157,720
1,055,947
3,922,012
Cost of Revenue
650,004
618,944
540,391
968,487
1,370,698
Gross Profit
970,753
753,757
617,329
87,460
2,551,314
Operating Expense
894,082
964,475
1,835,979
1,733,303
1,783,966
Operating Income
76,671
-210,718
-1,218,650
-1,645,843
767,348
Net Non Operating Interest Income Expense
23,550
16,008
33,209
-30,570
-15,908
Pretax Income
107,005
-112,716
-1,278,860
-1,872,613
1,136,434
Tax Provision
107,248
109,673
191,207
58,874
65,733
Net Income Common Stockholders
-26,495
-204,690
-561,296
-675,874
-52,614
Diluted NI Available to Com Stockholders
-26,495
-204,690
-561,296
-675,874
-52,614
Basic EPS
-0.19
-1.47
-4.03
-4.86
-0.38
Diluted EPS
-0.19
-1.47
-4.03
-4.86
-0.38
Basic Average Shares
138,851.36
139,307
139,346
139,126
138,970
Diluted Average Shares
139,307
139,307
139,346
139,126
138,970
Total Expenses
1,544,086
1,583,419
2,376,370
2,701,790
3,154,664
Net Income from Continuing & Discontinued Operation
-26,495
-204,690
-561,296
-675,874
-52,614
Normalized Income
-22,043.80
-199,508.40
-549,741.60
-658,967.60
-73,205.82
Interest Income
51,438
52,397
89,068
8,883
3,160
Interest Expense
27,888
36,389
55,859
39,453
19,068
Net Interest Income
23,550
16,008
33,209
-30,570
-15,908
EBIT
134,893
-76,327
-1,223,001
-1,833,160
1,155,502
EBITDA
309,646
98,914
-1,044,618
-1,641,514
1,353,930
Reconciled Cost of Revenue
650,004
618,944
540,391
968,487
1,370,698
Reconciled Depreciation
174,753
175,241
178,383
191,646
198,428
Net Income from Continuing Operation Net Minority Interest
-26,495
-204,690
-561,296
-675,874
-52,614
Total Unusual Items Excluding Goodwill
-5,564
-6,477
-14,443
-21,133
21,856
Total Unusual Items
-5,564
-6,477
-14,443
-21,133
21,856
Normalized EBITDA
315,210
105,391
-1,030,175
-1,620,381
1,332,074
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,112.80
-1,295.40
-2,888.60
-4,226.60
1,264.18
12/31/2021 - 12/31/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6547.TWO Medigen Vaccine Biologics Corporation
48.95
-1.61%
 
4174.TWO OBI Pharma, Inc.
35.35
+2.17%
 
6492.TWO Senhwa Biosciences, Inc.
33.20
+0.61%
 
3205.TWO Sagittarius Life Science Corp
43.95
+4.02%
 
4142.TW Adimmune Corporation
17.20
-1.99%
 
6589.TWO EirGenix Inc.
63.10
-0.94%
 
4168.TWO GlycoNex Incorporation
25.05
-3.65%
 
4130.TWO Genovate Biotechnology Co., Ltd.
21.40
-0.23%
 
4743.TWO Oneness Biotech Co., Ltd.
57.20
-0.69%
 
4147.TWO TaiMed Biologics Inc.
82.70
+1.10%